1997
DOI: 10.1016/s0190-9622(97)70061-6
|View full text |Cite
|
Sign up to set email alerts
|

A developmental toxicity study of tretinoin administered topically and orally to pregnant Wistar rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
11
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 12 publications
1
11
0
Order By: Relevance
“…The downregulation of Vangl1/2 in spinal region from E15.5 to E19.5 was remarkable, while they slightly decreased on cranial region from E15.5 to E19.5 compared with control group (all PB0.01). Seegmiller et al, 1997), which was proven in our study as well.…”
Section: Discussionsupporting
confidence: 85%
“…The downregulation of Vangl1/2 in spinal region from E15.5 to E19.5 was remarkable, while they slightly decreased on cranial region from E15.5 to E19.5 compared with control group (all PB0.01). Seegmiller et al, 1997), which was proven in our study as well.…”
Section: Discussionsupporting
confidence: 85%
“…Findings from animal developmental studies have shown that topically applied tretinoin causes an increase in skeletal variations, abortions, fetal death and cleft palate, and a decrease in fetal weight, some cases of which were dose related. [34][35][36][37][38][39][40] For instance, in one of these studies the maternal toxicity of topically applied tretinoin was severe enough to lead to a mortality rate of 20% in dams receiving a high dose. 37 Analysis of animal developmental toxicity studies suggests a lack of an embryofetal toxic effect.…”
Section: Discussionmentioning
confidence: 99%
“…[34][35][36][37][38][39][40] For instance, in one of these studies the maternal toxicity of topically applied tretinoin was severe enough to lead to a mortality rate of 20% in dams receiving a high dose. 37 Analysis of animal developmental toxicity studies suggests a lack of an embryofetal toxic effect. 41 Human data regarding possible fetal adverse effects of topical retinoids began to emerge as case reports in the late 1980s.…”
Section: Discussionmentioning
confidence: 99%
“…An earlier study in mice demonstrated that oral RA application at doses of 50 to 200 mg/ kg BW, administered at gestational days 8, 9, or 10, was associated with spina bifi da. In another case, oral retinoic acid administration at a dose of 10 mg/kg BW was associated with embryofetal alterations in Wistar rats (Seegmiller et al, 1997). In our histochemical study, a 10-mg/kg BW dose of RA at gestational days 8 through 10 had no teratogenic effects on NADPH-d-positive neurons of rat spinal cord at P1 or P21, although administration of an overdosage of RA during this time is conducive to malformations.…”
Section: Discussionmentioning
confidence: 46%